BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27591497)

  • 21. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
    Crago AM; Singer S
    Curr Opin Oncol; 2011 Jul; 23(4):373-8. PubMed ID: 21552124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
    Hoffman A; Ghadimi MP; Demicco EG; Creighton CJ; Torres K; Colombo C; Peng T; Lusby K; Ingram D; Hornick JL; Wang WL; Ravi V; Lazar AJ; Lev D; Pollock RE
    Cancer; 2013 May; 119(10):1868-77. PubMed ID: 23401071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and Treatment of Myxoid Liposarcomas: Histology Matters.
    Abaricia S; Hirbe AC
    Curr Treat Options Oncol; 2018 Oct; 19(12):64. PubMed ID: 30362022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare myxoid pleomorphic liposarcoma: a case report and literature review.
    Shen Y; Zhao L; Li A; Peng Q; Liu Q; Wang L; Liu Z
    J Clin Pathol; 2024 Apr; 77(5):358-362. PubMed ID: 38123348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposarcoma of the pleural cavity: clinical and pathologic features of 4 cases with a review of the literature.
    Okby NT; Travis WD
    Arch Pathol Lab Med; 2000 May; 124(5):699-703. PubMed ID: 10782150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
    Keung EZ; Lazar AJ; Torres KE; Wang WL; Cormier JN; Ashleigh Guadagnolo B; Bishop AJ; Lin H; Hunt KK; Bird J; Lewis VO; Patel SR; Wargo JA; Somaiah N; Roland CL
    BMC Cancer; 2018 Sep; 18(1):913. PubMed ID: 30249211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dedifferentiated liposarcoma of the spermatic cord: a series of 42 cases.
    Kryvenko ON; Rosenberg AE; Jorda M; Epstein JI
    Am J Surg Pathol; 2015 Sep; 39(9):1219-25. PubMed ID: 25828386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological therapies for Liposarcoma.
    Saponara M; Stacchiotti S; Gronchi A
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):361-377. PubMed ID: 28135854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent Pleomorphic Myxoid Liposarcoma in a Patient With Li-Fraumeni Syndrome.
    Zare SY; Leivo M; Fadare O
    Int J Surg Pathol; 2020 Apr; 28(2):225-228. PubMed ID: 31559875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current management options for liposarcoma and challenges for the future.
    Kollár A; Benson C
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):297-306. PubMed ID: 24397249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of FUS-CHOP fusion gene in paraffin-embedded tissues and its clinicopathologic significance for myxoid/round cell liposarcomas].
    Xiang H; Wang J; Sun MH; Lu L; Shui RH; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):28-32. PubMed ID: 15796878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.
    Avallone G; Roccabianca P; Crippa L; Lepri E; Brunetti B; Bernardini C; Forni M; Olandese A; Sarli G
    Vet Pathol; 2016 Jul; 53(4):773-80. PubMed ID: 26993784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up.
    Lemeur M; Mattei JC; Souteyrand P; Chagnaud C; Curvale G; Rochwerger A
    Orthop Traumatol Surg Res; 2015 Feb; 101(1):103-7. PubMed ID: 25583234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposarcoma in the oral and maxillofacial region: an analysis of 10 consecutive patients.
    Zheng JW; Wang Y
    J Oral Maxillofac Surg; 1994 Jun; 52(6):595-8. PubMed ID: 8189297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases.
    Sioletic S; Dal Cin P; Fletcher CD; Hornick JL
    Histopathology; 2013 Jan; 62(2):287-93. PubMed ID: 23020289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myxoid/round cell liposarcoma of the brachial plexus].
    Giner J; Isla A; Hernández B; Nistal M
    Neurocirugia (Astur); 2014; 25(6):290-3. PubMed ID: 25126709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed myxoid/round cell liposarcoma of the scalp.
    Newlands SD; Divi V; Stewart CM
    Am J Otolaryngol; 2003; 24(2):121-7. PubMed ID: 12649828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myxoid liposarcoma of the foot: a study of 8 cases.
    Bekers EM; Song W; Suurmeijer AJ; Bonenkamp JJ; van der Geest IC; Braam PM; Ploegmakers MJ; Desar IM; Tops BB; van Gorp JM; Creytens DH; Mentzel T; Flucke U
    Ann Diagn Pathol; 2016 Dec; 25():37-41. PubMed ID: 27806844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma.
    Steinmann S; Gali-Muhtasib H; Huebner K; Al-Halabi R; Abou Merhi R; Aman P; Agaimy A; Haller F; Schneider-Stock R
    Cancer Lett; 2015 Oct; 367(2):147-56. PubMed ID: 26225840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models.
    Martinez-Cruzado L; Tornin J; Rodriguez A; Santos L; Allonca E; Fernandez-Garcia MT; Astudillo A; Garcia-Pedrero JM; Rodriguez R
    Neoplasia; 2017 Jun; 19(6):460-470. PubMed ID: 28494349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.